GRUPOS DE INVESTIGACIÓN

Caracterització dels equips d?atenció primària de Catalunya i predicció dels ingressos hospitalaris evitables durant el període 2018-2022

Characterisation and risks of long-term COVID-19 outcomes using large real world data

Characterization of incidental and chronic use of macrolides in patients with asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap syndrome (ACOS); a pharmacoepidemiologic drug utilization study with data mapped to the Observational Medical Outcomes Partnership - Common Data Model (OMOP-CDM)

CLEAN - CARDIOVASCULAR EFFECTS AND RISK ASSOCIATED WITH EXPOSURE TO MICROPLASTICS AND NANOPLASTICS

Comorbidity prevalence between HIV positive and HIV negative patients over 40 years of age.

Comparación de la efectividad de fármacos en primera línea de tratamiento preventivo de la migraña en Atención Primaria: ensayo clínico pragmático. Estudio PREMI

COMPARTIM, App per persones amb DI lleugera o moderada

CONCEPT-STROKE Effectiveness and efficiency of acute ischemic stroke care pathways in five Spanish regions

Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad - Validación SNAC-K (OMOP)

DARWIN EU - Age-specific incidence rates of RSV-related disease in Europe

DARWIN EU - Background rates of serious adverse events to contextualise safety signals in a clinical trial in adolescent and adult patients with severe asthma.

DARWIN EU ? EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant

DARWIN EU® - Antipsychotic prescribing in Europe: a descriptive analysis of trends and patient characteristics

DARWIN EU® - Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics

DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives

DARWIN EU® - Azathioprine - user characteristics

DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

DARWIN EU® - Characterising STOPP criteria medication use in people with recurrent falls

DARWIN EU® - Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data

DARWIN EU® - Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products